Your browser doesn't support javascript.
loading
Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers.
Soeteman, Djøra I; Resch, Stephen C; Jalal, Hawre; Dugdale, Caitlin M; Penazzato, Martina; Weinstein, Milton C; Phillips, Andrew; Hou, Taige; Abrams, Elaine J; Dunning, Lorna; Newell, Marie-Louise; Pei, Pamela P; Freedberg, Kenneth A; Walensky, Rochelle P; Ciaranello, Andrea L.
Afiliação
  • Soeteman DI; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Resch SC; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Jalal H; Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Dugdale CM; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Penazzato M; HIV and Hepatitis Department, World Health Organization, Geneva, Switzerland.
  • Weinstein MC; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Phillips A; Institute for Global Health, University College, London, UK.
  • Hou T; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Abrams EJ; ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, New York.
  • Dunning L; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Newell ML; Institute for Development Studies, Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Pei PP; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Freedberg KA; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Walensky RP; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Ciaranello AL; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
MDM Policy Pract ; 5(1): 2381468320932894, 2020.
Article em En | MEDLINE | ID: mdl-32587893
ABSTRACT
Background. Metamodels can simplify complex health policy models and yield instantaneous results to inform policy decisions. We investigated the predictive validity of linear regression metamodels used to support a real-time decision-making tool that compares infant HIV testing/screening strategies. Methods. We developed linear regression metamodels of the Cost-Effectiveness of Preventing AIDS Complications Pediatric (CEPAC-P) microsimulation model used to predict life expectancy and lifetime HIV-related costs/person of two infant HIV testing/screening programs in South Africa. Metamodel performance was assessed with cross-validation and Bland-Altman plots, showing between-method differences in predicted outcomes against their means. Predictive validity was determined by the percentage of simulations in which the metamodels accurately predicted the strategy with the greatest net health benefit (NHB) as projected by the CEPAC-P model. We introduced a zone of indifference and investigated the width needed to produce between-method agreement in 95% of the simulations. We also calculated NHB losses from "wrong" decisions by the metamodel. Results. In cross-validation, linear regression metamodels accurately approximated CEPAC-P-projected outcomes. For life expectancy, Bland-Altman plots showed good agreement between CEPAC-P and the metamodel (within 1.1 life-months difference). For costs, 95% of between-method differences were within $65/person. The metamodels predicted the same optimal strategy as the CEPAC-P model in 87.7% of simulations, increasing to 95% with a zone of indifference of 0.24 life-months ( ∼ 7 days). The losses in health benefits due to "wrong" choices by the metamodel were modest (range 0.0002-1.1 life-months). Conclusions. For this policy question, linear regression metamodels offered sufficient predictive validity for the optimal testing strategy as compared with the CEPAC-P model. Metamodels can simulate different scenarios in real time, based on sets of input parameters that can be depicted in a widely accessible decision-support tool.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: MDM Policy Pract Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: MDM Policy Pract Ano de publicação: 2020 Tipo de documento: Article